Eli Lilly Market Cap

Eli Lilly has a market cap or net worth of $1.21 trillion as of November 6, 2026. It is the 12th most valuable company in the world and the 10th biggest in the United States. Its market cap has increased by 37.80% in one year.

Market Cap

1.21T

Enterprise Value

1.25T

1-Year Change

37.80%

Global Rank

#12

Country Rank

#10 United States

ChartMarket Cap Chart

Chart

Since December 1, 1998, Eli Lilly's market cap has increased from $99.25B to $1.21T, an increase of 1,115.22%. That is a compound annual growth rate of 9.35%.

Market Cap History

Date	Market Cap	% Change
Nov 6, 2026	1.27T	25.37%
Dec 31, 2025	1.02T	38.63%
Dec 31, 2024	732.87B	32.44%
Dec 29, 2023	553.37B	59.19%
Dec 30, 2022	347.61B	31.56%
Dec 31, 2021	264.23B	63.60%
Dec 31, 2020	161.51B	27.99%
Dec 31, 2019	126.19B	2.94%
Dec 31, 2018	122.58B	31.81%
Dec 29, 2017	93.00B	14.54%
Dec 30, 2016	81.20B	-13.04%
Dec 31, 2015	93.37B	21.55%
Dec 31, 2014	76.82B	33.69%
Dec 31, 2013	57.46B	0.39%
Dec 31, 2012	57.23B	18.95%
Dec 30, 2011	48.12B	19.08%
Dec 31, 2010	40.41B	-1.52%
Dec 31, 2009	41.03B	-10.38%
Dec 31, 2008	45.79B	-24.40%
Dec 31, 2007	60.56B	2.72%
Dec 29, 2006	58.96B	-8.34%
Dec 30, 2005	64.32B	0.16%
Dec 31, 2004	64.22B	-18.68%
Dec 31, 2003	78.97B	10.71%
Dec 31, 2002	71.33B	-19.21%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

Company	Market Cap
Johnson & Johnson	664.95B
AbbVie	514.92B
Merck & Co.	361.73B
Novartis AG	306.63B
AstraZeneca	288.75B
Amgen	249.05B
Gilead Sciences	207.00B
Novo Nordisk	177.19B

Market Cap Rankings